Civic AI
Procurement intelligence
Federal contract award
NICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS (PK), PHARMACODYNAMIC (PD) EFFECTS, SAFETY, AND CONTRACEPTIVE EFFICACY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-ACTING INJECTABLE: NON-SEVERABLE
OREGON HEALTH & SCIENCE UNIVERSITY · Department of Health and Human Services
- Value
- $97,767
- Start
- Aug 1, 2025
- End
- Apr 30, 2026
- Action date
- Jan 28, 2026
- PIID
- 75N94025F00001
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- PORTLAND, OR
- Award type
- DELIVERY ORDER
Description
NICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS (PK), PHARMACODYNAMIC (PD) EFFECTS, SAFETY, AND CONTRACEPTIVE EFFICACY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-ACTING INJECTABLE: NON-SEVERABLE
Need modifications, related awards, and vendor peers? Open the full award workspace.